The sensitivity of BCR-ABL1+ B-ALL to genetic and PROTAC-mediated CDK8 depletion has been already shown to particularly depend on subsequent inactivation of mTORC1 activity [37]. This evidence concerns the gene CDK8 and acute lymphoblastic leukemia.